Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus
Recruiting
Observational Study
Systemic Lupus Erythematosus
Lupus Nephritis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 16 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 90 (estimated)
- Sponsor
- Sohag University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to investigate the association between the systemic immune-inflammation index and disease activity, as well as lupus nephritis in patients with systemic lupus erythematosus
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* o Older than 16 years
* In a patient with SLE, patients who fulfill the criteria of the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR).
* In patients with LN, patients whose diagnosis is confirmed by kidney biopsy and pathohistologic…
Contacts